BioSpace News Archive

Increasing Adoption of Health Supplements is Expected to Drive Vitamin A Deficiency Market Growth by 2030 - Reports and Data

The latest market analysis report published by Reports and Data, titled ‘Global Vitamin A Deficiency Market – Forecast to 2030,’ thoroughly examines the Vitamin A Deficiency industry to provide essential data & information for the targeted readers.

September 26, 2022
·
6 min read
In Vitro Fertilization Market Size Will Reach USD 36.51 Billion in 2028 | Increase in Incidence of Male and Female Infertility and Growing Number of Women in Workforce will Drive Industry Growth

The global In Vitro Fertilization (IVF) market size was USD 18.08 Billion in 2020 and is expected to reach USD 36.51 Billion at a CAGR of 9.1% in 2028, according to latest analysis by Emergen Research.

September 26, 2022
·
7 min read
Companion Diagnostics Market Trend | Demand for Customized Medication and Tailored Treatment Coupled with the Recognition by Industry Participants of the Co-Development Paradigm of Drug Diagnostics will Drive Industry Demand

The global Companion Diagnostics Market size was USD 2.43 Billion in 2019 and is forecasted to reach USD 9.72 Billion by 2027 growing at a CAGR of 18.9% during forecast period, according to a new report by Emergen Research.

September 26, 2022
·
7 min read
Regenerative Medicine Market Size Will Reach USD 37.10 Billion in 2030 | Increasing Investments Toward R&D for Tissue Engineering and Regenerative Medicine will Drive the Industry Demand

The global regenerative medicine market size reached USD 9.80 Billion in 2021 and is expected to reach USD 37.10 Billion in 2030 registering a CAGR of 15.9% during the forecast period, according to latest analysis by Emergen Research.

September 26, 2022
·
7 min read
Business

IDEX Corporation to Webcast Third Quarter 2022 Earnings Call

IDEX CORPORATION (NYSE:IEX) announced today that it has scheduled the broadcast of the company’s third quarter earnings conference call over the Internet on Wednesday, October 26, 2022 at 9:30 a.m. CT.

September 26, 2022
·
2 min read
Centers for Medicare & Medicaid Services issues preliminary payment rate determination for Immunovia’s IMMray PanCan-d test

Immunovia AB announced, that the Centers for Medicare & Medicaid Services published a preliminary payment determination implying a price of $897 for the IMMray PanCan-d test.

September 26, 2022
·
2 min read
Biotech Bay

Reviva Pharmaceuticals to Present at the Lytham Partners Fall 2022 Investor Conference

Reviva Pharmaceuticals Holdings, Inc. announced that Laxminarayan Bhat, Ph.D., Founder, President, and CEO of Reviva will present at the Lytham Partners Fall 2022 Investor Conference being held September 28–29, 2022 and invites investors to participate via virtual one-on-one meetings.

September 26, 2022
·
3 min read
Pharm Country

BD, CerTest Biotec Announce US Commercial Launch of Monkeypox Assay

BD, a leading global medical technology company, and CerTest Biotec announced their newly developed molecular polymerase chain reaction assay for monkeypox virus is now commercially available globally, including in the United States, for research use only applications by laboratories.

September 26, 2022
·
3 min read
Policy

Pfizer and BioNTech Submit Application to U.S. FDA for Emergency Use Authorization of Omicron BA.4/BA.5-Adapted Bivalent Vaccine Booster in Children 5 Through 11 Years of Age

Pfizer Inc. and BioNTech SE announced they have completed a submission to the U.S. Food and Drug Administration requesting Emergency Use Authorization of a 10-µg booster dose of the companies’ Omicron BA.4/BA.5-adapted bivalent COVID-19 vaccine for children 5 through 11 years of age.

September 26, 2022
·
22 min read
Policy

Bio-Techne Files Patent Infringement Lawsuit Against Molecular Instruments

Bio-Techne Corporation today announced that it has taken legal action in the United Kingdom to halt the infringement of its patented RNAscope® ISH technology by Molecular Instruments, Inc.

September 26, 2022
·
1 min read